Critical Outcome Technologies Closes $1.5 Million Private Placement - Seite 3

For more information, visit www.criticaloutcome.com

Notice to Readers:

Information contained in this press release may contain certain statements which constitute "forward- looking statements" as such term is defined under applicable securities laws. For example, the statements "Additional funding is expected from an upcoming second tranche to be closed in the next few weeks" and "We continue to expect to report secondary and exploratory endpoints from the gynecological arm of the trial later this year, and to report top-line data from the HNSCC expansion arm in 2018" are forward-looking statements. Forward‐looking statements by their nature are not guarantees of future performance and are based upon management's current expectations, estimates, projections and assumptions. COTI operates in a highly competitive environment that involves significant risks and uncertainties, which could cause actual results to differ materially from those anticipated in these forward‐looking statements. Management of COTI considers the assumptions on which these forward‐looking statements are based to be reasonable, but as a result of the many risk factors, cautions the reader that actual results could differ materially from those expressed or implied in these forward-looking statements. Information in this press release should be considered accurate only as of the date of the release and may be superseded by more recent information disclosed in later press releases, filings with the securities regulatory authorities or otherwise. Except as required by law, COTI assumes no obligation to update forward-looking statements should circumstances or management's expectations, estimates, projections and assumptions change.

Critical Outcome Technologies Inc.
Alison Silva
President and CEO
1-800-798-8680
[e-mail]